Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

AZN AstraZeneca PLC

78,18

0,16 (0,21%)

Zuletzt aktualisiert: 20:18:27

Verzögert um 15 Minuten

Italy Blocked Export of AstraZeneca Covid-19 Vaccines to Australia, Sources Say

By Giovanni Legorano

ROME-Italy blocked the export of AstraZeneca Covid-19 vaccines to Australia in a move coordinated with European Union authorities, according to two people familiar with the matter, reflecting mounting frustration in Europe with slow vaccine deliveries.

Write to Giovanni Legorano at giovanni.legorano@wsj.com

(END) Dow Jones Newswires

March 04, 2021 11:38 ET (16:38 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
Von Sep 2024 bis Okt 2024

Click Here for more AstraZeneca Charts.

AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
Von Okt 2023 bis Okt 2024

Click Here for more AstraZeneca Charts.

News AstraZeneca PLC

AIRSUPRA® (albuterol/budesonide) demonstrated statistically significant and clinically meaningful reduction in the risk of severe exacerbations in patients with intermittent or mild persistent asthma in BATURA Phase III trial
Montag 7 Oktober 2024 (2 Wochen vor) • Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 7 Oktober 2024 (2 Wochen vor) • Edgar (US Regulatory)

CALQUENCE® (acalabrutinib) granted Priority Review in the US for patients with untreated mantle cell lymphoma
Donnerstag 3 Oktober 2024 (2 Wochen vor) • Business Wire

ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US for patients with HER2-low or HER2-ultralow metastatic breast cancer who have received at least one line of endocrine therapy
Dienstag 1 Oktober 2024 (2 Wochen vor) • Business Wire

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
Donnerstag 26 September 2024 (3 Wochen vor) • GlobeNewswire Inc.

TAGRISSO® (osimertinib) approved in the US for patients with unresectable, Stage III EGFR-mutated lung cancer
Donnerstag 26 September 2024 (3 Wochen vor) • Business Wire

Datopotamab deruxtecan final overall survival results reported in patients with metastatic HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial
Montag 23 September 2024 (4 Wochen vor) • Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 23 September 2024 (4 Wochen vor) • Edgar (US Regulatory)

Apollo Eyes $5 Billion Investment in Intel; TSMC and Samsung Explore UAE Chip Projects, and More
Montag 23 September 2024 (4 Wochen vor) • IH Market News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 23 September 2024 (4 Wochen vor) • Edgar (US Regulatory)

FLUMIST approved for self-administration in the US
Freitag 20 September 2024 (4 Wochen vor) • Business Wire

FASENRA approved in the US for eosinophilic granulomatosis with polyangiitis
Mittwoch 18 September 2024 (1 Monat vor) • Business Wire

Weitere AstraZeneca PLC News-Artikel

Deutsche Lufthansa

Financial Select Sector

JP Morgan Chase

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen